Valuation7 min read
Pre-Revenue Startup Valuation: 3 Methods and an Example
With no revenue and no profit, a startup cannot be valued with an EBITDA multiple or a reliable DCF: you compare it with other young companies and score what reduces its risks. The Berkus method, the scorecard and funding-round comparables each produce a figure, and it is the cross-check between them that gives you a defensible range.

Why pre-revenue startup valuation is different
Pre-revenue startup valuation is a different exercise because the usual tools barely work for a company that does not yet sell anything. An EBITDA multiple applied to a negative result gives a negative value. A DCF (discounting future cash flows) depends entirely on seven-year forecasts that nobody can check: change the growth rate by one point and the value doubles. As for net assets, they often amount to the remaining cash and a laptop.
The value of a startup before its first revenue lies elsewhere: the probability that the team, the product and the market turn an idea into a business. The methods below do not claim to measure that value to the penny. They structure the conversation between founders and investors, and they are used to set the pre-money valuation, meaning the value of the company before the new money comes in, covered in our article on pre-money valuation.
We will apply them to Verdalis, a fictional startup: three founders, a soil-moisture sensor for vineyards, a prototype tested at four estates, and no sales. It wants to raise €500k to industrialise the sensor.
The Berkus method: an amount for each risk removed
Devised by the American investor Dave Berkus in the 1990s, the method assigns a sum to each of the five elements that reduce the risk of a young company. Each element is capped; Berkus originally proposed $0.5m per element. In France, investors set the cap according to their own market: we use €500k per element here, so €2.5m at most.
| Element | Risk reduced | Cap | Verdalis |
|---|---|---|---|
| Sound idea (base value) | Product risk | €500k | €350k |
| Working prototype | Technology risk | €500k | €300k |
| Quality of the team | Execution risk | €500k | €400k |
| Strategic partnerships | Market risk | €500k | €150k |
| First sales or launch | Commercial risk | €500k | €50k |
| Total | €2,500k | €1,250k |
Verdalis comes out at €1.25m. The team scores well (an agronomist, an electronics engineer and a salesperson who has sold to winegrowers), the prototype works but is not yet mass-produced, and the four pilot estates are not yet paying customers.
The method has two qualities: it forces you to justify each amount, and it caps the value of a company with no revenue, which avoids extravagant figures. Its limit lies in the cap itself: it is a convention, and a cap of €400k would give €1.0m for the same scores. Berkus reserved it for companies without revenue in any case; once the first sales arrive, you need to move on to something else.
The scorecard method: compare with a typical startup in your market
The scorecard method (or weighted-factor method), popularised by the investor Bill Payne, starts from the pre-money valuation of comparable startups that have recently raised in your sector and region. It then adjusts that figure according to whether your company is better or worse than average on seven weighted criteria.
Suppose that recent seed rounds for comparable agricultural or sensor startups with no revenue were done at around €1.5m pre-money. That figure is an assumption of the example: for your own file, it is built from published funding rounds (see the next section).
| Criterion | Weight | Verdalis versus the average | Contribution |
|---|---|---|---|
| Team | 30% | 125% | 37.5% |
| Market size | 25% | 150% | 37.5% |
| Product and technology | 15% | 100% | 15.0% |
| Competition | 10% | 75% | 7.5% |
| Marketing, sales and partnerships | 10% | 80% | 8.0% |
| Need for further funding | 5% | 100% | 5.0% |
| Other factors | 5% | 100% | 5.0% |
| Total | 100% | 115.5% |
Each criterion's contribution is its weight multiplied by its score; their sum, 115.5%, is applied to the benchmark: €1.5m × 1.155 ≈ €1.73m. Verdalis gains on the team and the market (water management in vineyards is a growing topic), but loses on competition, which is already present with connected weather stations.
The scorecard has the advantage of anchoring the value in the real market for funding rounds. Its weak point is the benchmark: if the starting average is badly chosen, no amount of scoring can fix it.
Funding-round comparables: finding the right benchmark
The two previous methods both need a yardstick. It comes from comparable funding rounds: startups in the same sector, at the same stage (no revenue or a few pilot customers), that raised in the last twelve to eighteen months.
Where to find these figures:
- the specialist press and funds' press releases, which announce the amount raised but rarely the valuation;
- paid venture capital databases, which are more complete;
- the articles of association and the documents filed with the French commercial register after a capital increase, which give the number of shares issued and their price, and therefore the implied valuation;
- your network: business angel networks, incubators, other founders.
Three precautions before using a figure:
- Check whether it is pre-money or post-money. A "€2m valuation" announced after a €500k round may mean €1.5m or €2m before the money went in.
- Be wary of convertible instruments. A BSA-AIR (a French instrument similar to a SAFE: a warrant for shares under a fast investment agreement) does not set a valuation: it sets a cap. That cap is not a price.
- Compare identical stages. A startup that already has €200k of recurring revenue is not a benchmark for a company with no customers.
Cross-checking the methods and working out the dilution
A third check comes from the venture capital method, the one the investor applies on their side. They imagine a resale value in six to eight years, divide it by the multiple they are aiming for, and allow for the dilution from later rounds.
For Verdalis: if the company is worth €30m at exit, the seed investor aims for ten times their money and expects to keep only 70% of their stake after later rounds, the maximum post-money they will accept is 30 × 0.70 ÷ 10 = €2.1m, which is a pre-money of 2.1 − 0.5 = €1.6m. The target multiple is high because most startups funded at this stage return nothing to their investors.
| Method | Verdalis pre-money |
|---|---|
| Berkus (€500k cap per element) | €1.25m |
| Scorecard (€1.5m benchmark) | €1.73m |
| Venture capital (€30m exit, 10x, 70% retained) | €1.60m |
The three figures overlap between €1.25m and €1.75m. A pre-money of €1.5m is easy to defend. With €500k raised, the post-money is €2.0m and the investor receives 0.5 ÷ 2.0 = 25% of the share capital. The founders go from 100% to 75%, before any employee incentive plan. To follow what that stake becomes over successive rounds, map out the cap table across several rounds.
Mistakes that cost dearly
- Valuing on a five-year business plan. Forecast revenue of €20m in year 5, multiplied by a listed-company multiple, convinces no investor. At best they will go with the venture capital method, using a high multiple of their money.
- Aiming for the highest valuation. An inflated pre-money at seed makes the Series A difficult; if it is done lower, the price-adjustment clauses are triggered against the founders.
- Forgetting the clauses. A liquidation preference, a price-adjustment "ratchet" and an incentive plan included in the pre-money change what the founders keep, at the same valuation.
- Staying with these methods for too long. As soon as the company invoices, even at a loss, it is valued with revenue multiples and a turnaround DCF, as for a loss-making company.
Preparing the discussion with investors
Arrive with the three calculations, your written assumptions (Berkus cap, scorecard benchmark, criterion-by-criterion scores, exit value) and the dilution that follows. Investors will redo their own scoring: your aim is not to impose a figure, but to show that your range rests on verifiable elements. Then have the shareholders' agreement and the clauses reviewed by a lawyer before signing.
Is your startup already invoicing? Run a free valuation from its name or SIREN, with a free account; if your accounts are not published, enter your figures. It is an estimate, neither a certified valuation nor investment advice: have the valuation and the clauses of your funding round validated by your accountant and your lawyer.


